is glp 1 semaglutide or tirzepatide & are transforming diabetes & obesity management. These GLP-1 receptor agonists offer benefits from glycemic control to weight loss and cardiovascular risk reduction, emphasizing their broad impact. Read more from Semaglutide vs Tirzepatide: Key Differences

331 While these findings suggest that finerenone may delay the progression of nonproliferative DR in T2D patients with DKD, the lack of randomization and the limited number of endpoint events restrict the strength of these conclusions

Summary of included pre-clinical and mechanistic studies regarding the effects of GLP-1-RAs on mental health outcomes)

Prescribers should monitor the FDAs bulk drug substances list for the formal rule publication

This section covers the interaction patterns that matter most for GLP-1 therapy

Jardiance Exploring Treatment Options Spotlight on Featured content 86% of cancers aren't caught by recommended screenings